Patent · US Active

Anti-thrombotic compounds

US10105353B2 · kind B2 · utility

0Cited by

4References

5Claims

0Family size

Assignee

IPCA LABORATORIES LIMITED · IN

Inventors

Ashok Kumar · Jamkhed, IN
Satish Rajanikant Soudagar · Mumbai, IN
Nellithanath Thankachen Byju · Mumbai, IN
Gaurav Sahal · Mumbai, IN
Arpana Prashant Mathur · Mumbai, IN
Sanjay Pandurang Gawade · Mumbai, IN
Dinesh Kanji Bhadra · Mumbai, IN
Devki Moje · Mumbai, IN

Key dates

Filing date	Oct 3, 2013
Grant date	Oct 23, 2018
Priority date	—
Expiry date	Oct 3, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

New compounds, namely, (7aS,2′S)-2-oxoclopidogrel and its pharmaceutically acceptable salts thereof are disclosed for treatment or prophylaxis of thrombo-embolism and/or cardiovascular diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.